Theravance Biopharma | DEF 14A: Definitive information statements
Apr 5 16:22 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Apr 4 18:21 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sawaf Aziz
Apr 4 18:17 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Miller Aine
Apr 4 18:17 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Grimaud Brett A.
Apr 4 18:17 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Farnum Rhonda
Apr 4 18:11 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Mar 19 18:08 ET
Theravance Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Weiss Asset Management LP BIP GP LLC WAM GP LLC Andrew M. Weiss Ph.D.(Weiss Asset Management LP 15.5%)
Mar 5 09:02 ET
Theravance Biopharma | 10-K: Annual report
Mar 1 16:37 ET
Theravance Biopharma | 8-K: Current report
Feb 28 22:50 ET
Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Feb 26 16:24 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Feb 22 20:18 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sawaf Aziz
Feb 22 20:13 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Miller Aine
Feb 22 20:13 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Grimaud Brett A.
Feb 22 20:13 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer GRAHAM RICHARD A
Feb 22 20:08 ET
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Farnum Rhonda
Feb 22 20:08 ET
Theravance Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Miller Aine
Feb 16 20:17 ET
Theravance Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Irenic Capital Management LP(5.5%),Irenic Capital Evergreen Master Fund LP(5.5%), etc.
Feb 14 16:04 ET
Theravance Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.01%)
Feb 13 22:33 ET
No Data
No Data